Welcome
Support Centre
29 August 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effect of mivacurium 200 and 250 mg/kg in children aged 6 months to 2 years (Eficacia del Mivacurium administrado a dosis de 200 y 205 µg/kg en niños de 6 meses a dos años de edad)
ISRCTN ISRCTN07742712
ClinicalTrials.gov identifier
Public title Effect of mivacurium 200 and 250 mg/kg in children aged 6 months to 2 years (Eficacia del Mivacurium administrado a dosis de 200 y 205 µg/kg en niños de 6 meses a dos años de edad)
Scientific title
Acronym N/A
Serial number at source HIM 97/011
Study hypothesis Patients undergoing an elective surgery of a planned duration not longer than 1 hour while requiring tracheal intubation during the procedure.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Mexico
Disease/condition/study domain Anesthesia in children 6-24 months
Participants - inclusion criteria 1. Children aged 6 to 24 months
2. Low surgical risk (American Society of Anesthesiologists [ASA] grade I)
3. Suffering any ophthalmic, oto-rhynologic, plastic or orthopaedic disease
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2000
Anticipated end date 01/01/2001
Status of trial Completed
Patient information material
Target number of participants 24
Interventions Patients randomly received an intravenous (iv) bolus dose of mivacurium 200 or 250 mg/kg. Isoflurane was administered to maintain anesthetic level during the surgical procedure. The times to onset of action and to spontaneous recovery of neuromuscular function were compared between groups. The area under-the-curve of the Heart Rate (HR), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) were also compared between groups.

Ancillary analyses: In every group, the HR and SBP and DBP data obtained 5 min after mivacurium was administered were compared to their respective baseline values. In order to evaluate the effect of age and weight into onset and recovery times (data from all children), a single linear regression analysis (y = mx + b) was performed between each of the onset and recovery times as the dependent or explained variable and age or weight as the independent variable.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. Fund to Encourage Research of the Mexican Institute of Social Security (Fondo de Fomento a la Investigacion of the Instituto Mexicano del Seguro Social) (Mexico) (grant ref: FP0038/988)
2. Secretariat of Public Education - National Council of Science and Technology (Secretraria de Educacion Publica - Consejo Nacional de Ciencia y Tecnologia [SEP-CONACyT]) (Mexico) (grant ref: 30591-M)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=11722796
Contact name Dr  AA  Nava-Ocampo
  Address Unit of Medical Research in Pharmacology
Centro Médico Nacional
  City/town Mexico City
  Zip/Postcode 03020
  Country Mexico
  Email navaocampo_aa@yahoo.com
Sponsor Federico Gomez Infant Hospital of Mexico (Hospital Infantil de Mexico Federico Gomez) (Mexico)
  Address Subdireccion de Investigacion
Dr. Marquez 162
Colonia Doctores
  City/town Mexico DF
  Zip/Postcode CP06720
  Country Mexico
Date applied 03/10/2001
Last edited 24/09/2007
Date ISRCTN assigned 03/10/2001
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central